TCL Archive GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL July 26, 2013
TCL Archive Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years May 9, 2014